TITLE

CARDIO3 BIOSCIENCES HAS GOOD PRE-CLINICAL DATA FOR C-CATH

PUB. DATE
April 2010
SOURCE
Worldwide Biotech;Apr2010, Vol. 22 Issue 4, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the results of a pre-clinical study of the proprietary C-Cath (r) catheter which is under development to administer a range of bio-therapeutics to the heart, conducted by Cardio3 BioSciences. The research revealed an increased retention rate of cells within the heart muscle when using C-Cath which could reduce the administered dose while increasing the product's potency. The results support an earlier study showing improved retention of microparticles and a rage of cell-20 types using C-Cath.
ACCESSION #
48899739

 

Related Articles

  • Cardio3 wins CE mark for C-Cath.  // Medical Device Daily;5/15/2012, Vol. 16 Issue 94, p10 

    The article reports that a CE marking was received by Cardio3 for its mycardial C-Cath injection catheter.

  • Cardio3 launches Rochester subsidiary.  // Medical Device Daily;9/27/2011, Vol. 15 Issue 184, p8 

    The article reports that Cardio3 BioSciences established its Cardio3 BioSciences subsidiary in Rochester, Minnesota.

  • Israel's Hadasit tests double lumen catheter.  // Biomedical Business & Technology;Oct2008, Vol. 31 Issue 10, p27 

    The article reports on the pre-clinical testing of a prototype of the Double Lumen PCI Guiding Catheter for use in the treatment of coronary artery disease by Israel's Hadasit. The second lumen of the catheter allows for a continuous medication infusion to the coronary artery during percutaneous...

  • New device simplifies catheter insertion.  // Engineer (Online Edition);9/2/2013, p2 

    The article reports on the development of a semi-automatic handheld device called SAGIV by students and clinicians in Israel for the rapid and safe intravenous (IV) insertion of catheters.

  • Care of long-term catheters.  // Primary Health Care;Feb2002, Vol. 12 Issue 1, p31 

    Provides guidelines in the care of patients with long-term catheters. Need for the dressing over the cannula site to be changed twice weekly; Flushing of the catheter at regular intervals to prevent clotting; Use of heparinized saline two or three times per week.

  • Treating recurrent catheter malfunction with alteplase is not advantageous. Little, M. A.; Walshe, J. J. // Kidney;Jul/Aug2002, Vol. 11 Issue 4, p164 

    Deals with a study which evaluated the effect of unblocking thrombosed catheters using indwelling alteplase with emphasis on estimating the additional benefit of repeated alteplase instillation. Methodology used in the study; Results and conclusion.

  • The Tape And Pin Works Best As A Catheter-Securing Device. Boyd, Leslie // RN;Jul2000, Vol. 63 Issue 7, p16 

    Reports on the finding that the traditional adhesive tape and pin method of securing a urethral urinary catheter is superior to a more expensive commercial device. Easiness of application of the adhesive tape and pin.

  • "No rent is small for migration of epidural catheter into sub-arachnoid space". Jadon, Ashok // Indian Journal of Anaesthesia;Nov2015, Vol. 59 Issue 11, p764 

    A letter to the editor is presented in response to the article "No rent is small for migration of epidural catheter into sub-arachnoid space," by Manish Tandon et al., published in a previous issue of the journal.

  • In response to comments on: No rent is small for migration of epidural catheter into subarachnoid space. Tandon, Manish; Pandey, Chandra Kant // Indian Journal of Anaesthesia;Nov2015, Vol. 59 Issue 11, p765 

    A reply by Manish Tandon in response to a letter to the editor about their article "No rent is small for migration of epidural catheter into sub-arachnoid space," published in a previous issue of the journal is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics